Mdm2 inhibitor nutlin-3 enhances the cytotoxic synergism induced by the combination of MEK1 inhibitor and arsenic trioxide (ATO) in AML cells.

被引：0
|
作者：
Lunghi, Paolo
Mazzera, Laura
Rizzoli, Vittorio
Bonati, Antonio
机构：
[1] Univ Parma, Dept Clin Sci, I-43100 Parma, Italy
[2] Univ Parma, Unit Hermatol, I-43100 Parma, Italy
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1364
引用
收藏
页码：398A / 398A
页数：1
相关论文
共 50 条
  • [1] MDM2 antagonist Nutlin-3 activates p53 and enhances the apoptotic synergism between MEK inhibitor and arsenic trioxide (ATO) in AML cells
    Lunghi, P.
    Mazzera, L.
    Rizzoli, V
    Bonati, A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 51 - 52
  • [2] Rescue of p53 function by MDM2 antagonist, Nutlin-3, enhances the apoptotic synergism between MEK1 inhibitor and arsenic trioxide
    Lunghi, P.
    Mazzera, L.
    Rizzoli, V.
    Bonati, A.
    [J]. EXPERIMENTAL HEMATOLOGY, 2007, 35 (09) : 86 - 86
  • [3] MDM2 INHIBITION SYNERGISTICALLY ENHANCES CYTOTOXICITY OF MEK1 INHIBITOR AND ARSENIC TRIOXIDE (ATO) IN AML BLASTS THAT RETAIN A FUNCTIONAL P53 PATHWAY
    Mazzera, L.
    Lunghi, P.
    Mangoni, M.
    Caramatti, C.
    Rizzoli, V
    Bonati, A.
    [J]. HAEMATOLOGICA, 2008, 93 : S47 - S47
  • [4] DNA damage response to the Mdm2 inhibitor Nutlin-3
    Verma, Rajeev
    Rigatti, Marc J.
    Belinsky, Glenn S.
    Godman, Cassandra A.
    Giardina, Charles
    [J]. BIOCHEMICAL PHARMACOLOGY, 2010, 79 (04) : 565 - 574
  • [5] The MDM2 inhibitor Nutlin-3 modulates dendritic cell-induced T cell proliferation
    Gasparini, Chiara
    Tommasini, Alberto
    Zauli, Giorgio
    [J]. HUMAN IMMUNOLOGY, 2012, 73 (04) : 342 - 345
  • [6] Potent in vitro and in vivo antitumor effects of MDM2 inhibitor nutlin-3 in gastric cancer cells
    Endo, Shinji
    Yamato, Kenji
    Hirai, Sachiko
    Moriwaki, Toshikazu
    Fukuda, Kuniaki
    Suzuki, Hideo
    Abei, Masato
    Nakagawa, Ichiro
    Hyodo, Ichinosuke
    [J]. CANCER SCIENCE, 2011, 102 (03) : 605 - 613
  • [7] Combining forces: Study of the cytotoxic effect of the MDM2 inhibitor Nutlin-3 in combination with CDDP in non-small cell lung cancer cell lines
    Deben, C.
    Rolfo, C.
    Deschoolmeester, V.
    Wouters, A.
    Peeters, M.
    Gil-Bazo, I.
    Lardon, F.
    Pauwels, P.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : 97 - 97
  • [8] Proteasome inhibitor combination with cytarabine or arsenic trioxide can potentiate apoptosis in AML cells.
    Liesveld, JL
    Abboud, CN
    Lu, CH
    Bechelli, J
    Rosell, K
    Phillips, G
    Lancet, JE
    [J]. BLOOD, 2005, 106 (11) : 194B - 194B
  • [9] p53 mutations induced by the MDM2 inhibitor nutlin-3 in p53 wild-type neuroblastoma cells
    Michaelis, M.
    Wass, M.
    Cinatl, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 69 : S72 - S72
  • [10] p53 expression controls prostate cancer sensitivity to chemotherapy and the MDM2 inhibitor Nutlin-3
    Chappell, William H.
    Lehmann, Brian D.
    Terrian, David M.
    Abrams, Stephen L.
    Steelman, Linda S.
    McCubrey, James A.
    [J]. CELL CYCLE, 2012, 11 (24) : 4579 - 4588
12345